Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2012
Methods to engineer and identify IgG1 variants with improved FcRn binding or effector functionRobert F Kelley, Y Gloria Meng
Mabs|May 3, 2017
Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidatesMiroslav Dostalek, Thomayant Prueksaritanont, Robert F Kelley
Drug Discovery Today|June 17, 2019
Protein conjugates and fusion proteins as ocular therapeuticsShrenik C Mehta, Robert F Kelley, Devin B Tesar
Thrombosis and Haemostasis|March 28, 2002
Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIaJihong Yang, Geoffrey F Lee, Markus A Riederer, et al.
Expert Opinion on Drug Delivery|November 30, 2018
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseasesWhitney Shatz, Jeffrey Aaronson, Stefan Yohe, et al.
Journal of Molecular Biology|January 18, 2006
Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid codeFrederic A Fellouse, Pierre A Barthelemy, Robert F Kelley, et al.
Journal of Pharmaceutical Sciences|December 31, 2020
An Approach to Bioactivity Assessment for Critical Quality Attribute Identification Based on Antibody-Antigen Complex StructureXuan Gao, Weiru Wang, Devin Tesar, et al.
Pageof 6